Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study)

Autor: Laharie, David, Bouhnik, Yoram, Vuitton, Lucine, Biron, Amélie, Pierron, Gaelle, Brault, Yves, Assing, Maryse, Bouzidi, Amira, Amiot, Aurélien, Nancey, Stephane
Zdroj: In Clinics and Research in Hepatology and Gastroenterology December 2024 48(10)
Databáze: ScienceDirect